Company: CRNX
Filing Date: 2025-04-04
Form Type: 8-K
Source: 0000950170-25-051179
Chunk: 2

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-04-04
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                                                      
         10.1      Independent Consultant Agreement, effective as of April 1, 2025, between Crinetics Pharmaceuticals, Inc. and Marc J. S. Wilson.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                      

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                         Crinetics Pharmaceuticals, Inc.        
  Date:      April 4, 2024      By:      /s/ R. Scott Struthers, Ph. D.         
                                         R. Scott Struthers, Ph. D.